Eldorado and WellDyneRx collaborate to create and market integrated claims processing software

Eldorado Computing, Inc. (ELDORADO), a leading provider of health benefit and claims management platforms, and WellDyneRx Inc., a national pharmacy benefits management (PBM) company, announced today that they are collaborating to create and market integrated claims processing software and PBM services to payers.

Under the alliance, ELDORADO will integrate its flagship Javelina™ browser-based claims and benefit management platform with WellDyneRx’s PBM services. ELDORADO and WellDyneRx will offer Javelina and PBM services to their respective clients, including third-party administrators, health plans unions and self-insured employers.

Javelina, which harnesses Java, open source, service-oriented architecture and other next-generation technologies, gives insurers a competitive edge by helping them analyze and manage their business more efficiently. The solution also facilitates improved cost reporting, and plan design and administration.

“We have chosen to work with ELDORADO because of the company’s strong commitment to delivering solutions that yield greater efficiencies and value for the payor community. This aligns perfectly with our culture and goal of providing leading-edge programs to health plans and their members,” said Damien Lamendola, president and CEO of WellDyneRx. “Javelina’s web-based approach and features add flexibility, speed and efficiency to claims and payment processing, allowing clients to tailor and respond rapidly to evolving market developments.”

“WellDyneRx is an innovative, forward-thinking organization that understands the role information technology plays in improving administrative, operational, financial and clinical efficiencies,” stated Tom Castleberry, ELDORADO’s vice chairman. “It recognizes that the business environment and management of millions of pharmacy claims demand highly reliable and scalable solutions, and we look forward to a very successful alliance.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Wearable devices may increase anxiety in atrial fibrillation patients despite perceived safety